A real-world study of Danlu capsule combined with Huangkui capsule in the intervention of granulomatous lobular mastitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083017

Enrollment

Unknown

Registered

2024-04-15

Start date

2024-04-15

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Granulomatous lobular mastitis

Interventions

Experimental group:Danlu capsule combined with Huangkui capsule

observation group:None

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) Those who meet the above diagnostic criteria of GLM Chinese and Western medicine; (2) Patients judged to be within 3 months of GLM recovery; (3) Volunteer to participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients during pregnancy and lactation, or who plan to become pregnant during the study period; (2) known allergy to the investigational drug; (3) People with mental and cognitive disabilities; (4) Poor compliance or other reasons deemed unsuitable for inclusion of researchers.

Design outcomes

Primary

Measure	Time frame
Breast specialist examination;Breast color ultrasound;	—

Secondary

Measure	Time frame
hepatic and renal function;	—

Countries

China

Contacts

Public ContactLiu Sheng

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

lshtcm@163.com+86 189 1776 3005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026